A Novel Therapeutic Approach for Anaplastic Thyroid Cancer Through Inhibition of LAT1

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-51144-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid Cancer.

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Lenvatinib as a Novel Treatment for Anaplastic Thyroid Cancer: A Retrospective Study

Oncology Letters
Cancer ResearchOncology
2018English

Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival

Case Reports in Oncological Medicine
Oncology
2013English

Unusual Manifestation of Anaplastic Thyroid Cancer

Acta medica (Hradec Kralove)
Medicine
2008English

Recent Progress of Genome Study for Anaplastic Thyroid Cancer

Genomics and Informatics
EvolutionEcologyGeneticsSystematicsHealth InformaticsBehavior
2013English

A New Aurora in Anaplastic Thyroid Cancer Therapy

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2014English

Nuclear Factor-kB in Thyroid Carcinogenesis and Progression: A Novel Therapeutic Target for Advanced Thyroid Cancer

Arquivos Brasileiros de Endocrinologia & Metabologia
2007English

Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Treatment With Lenvatinib to Anaplastic Thyroid Cancer :

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy